Nextgen Cancer Solutions Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2017.

2017 Hyderabad, Telangana, India Active

Last Updated: January 11, 2026

About Nextgen Cancer Solutions Private Limited

Nextgen Cancer Solutions Private Limited, a active private limited company, was established on 05 January 2017 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U74999TG2017PTC113900. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Venkata Subash Lingareddy (Director), Anuradha Acharya (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor, Royal Demeure Building, Plot No.12/2 Sector-1, Huda Techno Enclave, Madhapur, Hyderabad, Telangana, 500081.

Company Details

CIN/LLPIN
U74999TG2017PTC113900
Registration Number
113900
Incorporation Date
05 January 2017
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 11-01-2026
Paid Up Capital ₹ 0.10 M as on 11-01-2026
Company Age 9 Year, 1 Month
Last Filing with ROC 31 Mar 2024
Revenue Growth **** % (FY 2020)
Profit Growth **** -4.90% (FY 2020)
Ebitda **** -17.68% (FY 2020)
Net Worth -33.34% (FY 2020)
Total Assets -3.67% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Nextgen Cancer Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Nextgen Cancer Solutions Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Venkata Subash Lingareddy	Director	05 Jan 2017	Current
Anuradha Acharya	Director	05 Jan 2017	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nextgen Cancer Solutions.

Nextgen Cancer Solutions Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 4.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.34%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

-3.67%

*******

Profit or Loss

*******

-4.90%

*******

Net Worth

*******

-33.34%

*******

EBITDA

*******

-17.68%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nextgen Cancer Solutions?

Unlock access to Nextgen Cancer Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nextgen Cancer Solutions?

Unlock and access historical data on people associated with Nextgen Cancer Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nextgen Cancer Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextgen Cancer Solutions's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nextgen Cancer Solutions

Recent Activity within the Organization

Annual General Meeting

Nextgen Cancer Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

The activity Nextgen Cancer Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
31 Mar 2024
Director Appointment

Progress on Venkata Subash Lingareddy was appointed as a Director was appointed as a Director on 05 Jan 2017 & has been associated with this company since 9 years 1 month . was documented.
05 Jan 2017
Director Appointment

Anuradha Acharya was appointed as a Director was appointed as a Director on 05 Jan 2017 & has been associated with this company since 9 years 1 month . was recorded as a recent event.
05 Jan 2017
Company Incorporation

The activity Nextgen Cancer Solutions Private Limited was registered on 05 Jan 2017 with Roc Hyderabad & aged 9 years 1 month as per MCA records. was completed.
05 Jan 2017

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Nextgen Cancer Solutions Private Limited?

The CIN of Nextgen Cancer Solutions Private Limited is U74999TG2017PTC113900.

Where is Nextgen Cancer Solutions Private Limited headquartered?

Nextgen Cancer Solutions Private Limited is headquartered at 3Rd Floor, Royal Demeure Building, Plot No.12/2 Sector-1, Huda Techno Enclave, Madhapur, Hyderabad, Telangana, 500081.

When was Nextgen Cancer Solutions Private Limited incorporated?

Nextgen Cancer Solutions Private Limited was incorporated on 05 January 2017.

Who are the current directors of Nextgen Cancer Solutions Private Limited?

The current directors of Nextgen Cancer Solutions Private Limited are

What is the primary industry of Nextgen Cancer Solutions Private Limited?

The primary industry of Nextgen Cancer Solutions Private Limited is Pharma.

Is Nextgen Cancer Solutions Private Limited a listed company?

Nextgen Cancer Solutions Private Limited is unlisted.

What is the capital structure of Nextgen Cancer Solutions Private Limited?

The authorized capital of Nextgen Cancer Solutions Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Nextgen Cancer Solutions Private Limited?

The compliance status of Nextgen Cancer Solutions Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available